相关实验视频

Updated: Jun 15, 2025

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

细胞,结构基础和针对瘤中的小鼠双分钟X (MDMX) 的最新进展

Qikun Yin¹, Yuemiao Hu¹, Zhiwen Dong¹

¹School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, China.

Journal of medicinal chemistry

|August 26, 2024

概括

向瘤蛋白小鼠双分钟X (MDMX) 是癌症治疗的前景. 本综述探讨了MDMX结构和连接体,重点关注与MDM2的差异,以实现特定的MDMX向.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

鼠双分钟X (MDMX) 是一种瘤蛋白质,它负面调节瘤抑制剂p53,促进瘤发生.
在各种瘤中高MDMX表达使其成为癌症治疗的潜在治疗标.
对于开发选择性MDMX抑制剂来说,MDMX和MDM2之间的结构相似性是一个重大挑战.

研究的目的:

审查MDMX的结构,分布和监管.
总结MDMX连接体的结构特征和结构-活性关系 (SAR).
突出MDMX和MDM2之间的结构差异,以促进开发特定的MDMX准策略.

主要方法:

文献综述侧重于MDMX和MDM2的结构,功能和连接体相互作用.
在MDMX和MDM2连接体之间对结构特征和SAR的比较分析.
确定关键差异,以告知选择性治疗剂的设计.

主要成果:

详细概述MDMX的生物作用和监管机制.
已知MDMX配体及其SAR的综合摘要.
确定MDMX和MDM2之间的特定结构区别,这些区别可以用于向治疗.

结论:

开发特定的MDMX抑制剂对于有效的癌症治疗至关重要.
了解MDMX和MDM2之间的结构差异是实现治疗选择性的关键.
这一综述为设计新的策略提供了基础,以便在癌症治疗中专门针对MDMX.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

相关概念视频

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...